Authors
Latest:
Exploring the Threat of MDR-TB in the United StatesThe virulent pathogen has significant individual and public health implications.
Latest:
Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a SeatThe pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.
Latest:
A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet NeedThis training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
Latest:
Novel Cephalosporin Agent Shows Promise for Complicated UTIsA new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).
Latest:
Hepatitis A Outbreaks on the Rise in the USAn epidemiologist explores the changing epidemiology of a familiar disease.
Latest:
Psychobiotics: What Do We Know and Where Do We Go?Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.
Latest:
Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin DosingEvidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.
Latest:
An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban OutbreakAlthough Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
Latest:
SEP-1 Bundle Compliance Associated with Reduced Hospital ReadmissionsAs the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.
Latest:
Candida auris: Coming Soon to a Facility Near You?Epidemiologic and clinical lessons for the uninitiated.
Latest:
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract InfectionsSeveral recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Latest:
Phylogenetically Mapping the Evolution of the Zika Virus as It Spread Across the WorldAdriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.
Latest:
Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and AdvocacyInfectious diseases clinicians turn to Twitter as a tool for education and collaboration.
Latest:
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDSWhen the CD4 count seems too good to be true.
Latest:
Update on Candida auris: Statistics, Detection, and a Phase 2 TrialAs of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.
Latest:
Long-Acting Anti-MRSA Agents: One Dose to Cure?A review of the current literature and future directions.
Latest:
Resources Available for Patients with HIV Drug ResistanceThe panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
Latest:
Texas State Scientist on Rabies Eradication, Campus Reopening, and AMRDr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.
Latest:
Candida Auris: The Rise of a New Fungal ThreatCandida auris—Are we prepared for another multidrug-resistant pathogen?
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract InfectionsSeveral recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Latest:
Globalization of Antibiotic Stewardship Programs: The World Is WaitingThe globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
Latest:
Suffering through COVID-19: A Doctor's Personal JourneyFrontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.
Latest:
Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS GuidelinesHospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.
Latest:
ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT PatientsThis In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.
Latest:
Exploring Primary Prophylaxis for Invasive Pulmonary AspergillosisInvasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.
Latest:
Searching for the Cause of Hearing Loss in a Patient With HIVEarly diagnosis and treatment were essential to ensuring a good prognosis.
Latest:
Doravirine: Researchers DRIVE for a Drug Ahead of Its ClassA novel NNRTI hits the market, but what place will it have in treatment?
